Clinical trial
Outcomes of Early Raltegravir Experience: Comparison of Virologic Response in Regimens Not Containing a Protease Inhibitor in the Antiretroviral Background Regimen Versus a Protease Inhibitor in the Background Regimen
NCT00751530 is registered in ClinicalTrials.gov with Community Research Initiative of New England as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Outcomes of Early Raltegravir Experience: Comparison of Virologic Response in Regimens Not Containing a Protease Inhibitor in the Antiretroviral Background Regimen Versus a Protease Inhibitor in the Background Regimen
- Lead sponsor
- Community Research Initiative of New England
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2008
- Completion date
- June 15, 2009
- Enrollment
- 442 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.